Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Celltrion issued a correction disclosure regarding its Plant 3 construction, adjusting the final investment amount from KRW 274 billion to KRW 256.204 billion following the completion of construction settlement.
📊 Key Disclosure Content & Financial Highlights
- Overview
- Company: Celltrion, Inc. (Stock Code: 068270)
- Disclosure Type: New Facility Investment (Correction)
- Correction Filing Date: November 12, 2024 (Original Filing Date: November 18, 2020)
- Reason for Correction: Adjustment of investment amount following completion of construction settlement
- Key Correction Details
- Investment Amount: KRW 274,000,000,000 → KRW 256,204,000,000 (Decreased by approx. KRW 17.8B)
- Ratio to Equity: 9.43% → 8.81%
- Plant 3 Construction Investment Scale: KRW 274 billion → KRW 256.2 billion
- New Facility Investment Details
- Target: Construction of Plant 3 (Headquarters in Songdo-dong, Yeonsu-gu, Incheon)
- Purpose: Securing production capacity following product portfolio expansion
- Investment Period: January 1, 2021 – November 30, 2024
- Production Capacity Expansion:
- Existing Capacity: 190,000 liters (Plant 1: 100,000L, Plant 2: 90,000L)
- New Investment: 60,000 liters (Plant 3 construction)
- Total Capacity Post-Expansion: 250,000 liters (Based on bioreactor capacity)
- Financing Plan: Retained earnings and long-term borrowings
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verification of Plant 3 Validation Completion and Commercial Operation Status
This disclosure serves as official notification regarding the adjusted final investment amount following construction settlement for Celltrion’s Plant 3. As the investment period reaches its target end date (November 30, 2024), monitoring the completion of Plant 3 validation and subsequent commercial production operations is important. Relevant updates can be confirmed through future disclosures or official IR materials.
📢 Disclaimer & Source Notice
Source: This content was structured and generated based on official disclosure data from the Financial Supervisory Service’s DART system.
Investment Risk Warning: This material is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest solely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
